Prostate Cancer
Research


Volume 1 Number 1
January 2013


Home > Disciplines > Publications > Prostate Cancer Research > Volume 1, Year 2013 > Number 1, January



CONTENTS

▼


DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
PROGNOSIS
TREATMENT



DIAGNOSIS

▲

.

Carroll PR, Whitson JM, Cooperberg MR.
Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
J Clin Oncol. 2011 Feb 1;29(4):345-7. doi: 10.1200/JCO.2010.32.5308. Epub 2010 Dec 28.
Source | Full text | Similar articles



.

Detti B, Scoccianti S, Franceschini D, Cipressi S, Cassani S, Villari D, Gacci M, Pupi A, Vaggelli L, Saieva C, Pertici M, Livi L, Ceroti M, Nicita G, Carini M, Biti G.
Predictive factors of [18F]-Choline PET/CT in 170 patients with increasing PSA after primary radical treatment.
J Cancer Res Clin Oncol. 2013 Mar;139(3):521-8. doi: 10.1007/s00432-012-1354-4. Epub 2012 Nov 27.
Source | Full text | Similar articles



.

Penney KL, Sinnott JA, Fall K, Pawitan Y, Hoshida Y, Kraft P, Stark JR, Fiorentino M, Perner S, Finn S, Calza S, Flavin R, Freedman ML, Setlur S, Sesso HD, Andersson SO, Martin N, Kantoff PW, Johansson JE, Adami HO, Rubin MA, Loda M, Golub TR, Andrén O, Stampfer MJ, Mucci LA.
mRNA expression signature of Gleason grade predicts lethal prostate cancer.
J Clin Oncol. 2011 Jun 10;29(17):2391-6. doi: 10.1200/JCO.2010.32.6421. Epub 2011 May 2.
Source | Full text | Similar articles



.

Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR.
Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance.
J Clin Oncol. 2011 Jul 10;29(20):2795-800. doi: 10.1200/JCO.2010.33.0134. Epub 2011 May 31.
Source | Full text | Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION

▲

.

Chan JM, Oh WK, Xie W, Regan MM, Stampfer MJ, King IB, Abe M, Kantoff PW.
Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
J Clin Oncol. 2009 Aug 1;27(22):3577-83. doi: 10.1200/JCO.2008.18.8938. Epub 2009 Jun 15.
Source | Full text | Similar articles



.

Hemminki K, Sundquist J, Brandt A.
Familial mortality and familial incidence in cancer.
J Clin Oncol. 2011 Feb 20;29(6):712-8. doi: 10.1200/JCO.2010.30.5664. Epub 2011 Jan 4.
Source | Full text | Similar articles



.

Nguyen PL, Ma J, Chavarro JE, Freedman ML, Lis R, Fedele G, Fiore C, Qiu W, Fiorentino M, Finn S, Penney KL, Eisenstein A, Schumacher FR, Mucci LA, Stampfer MJ, Giovannucci E, Loda M.
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.
J Clin Oncol. 2010 Sep 1;28(25):3958-64. doi: 10.1200/JCO.2009.27.0793. Epub 2010 Aug 2.
Source | Full text | Similar articles



.

Platz EA, Lippman SM.
Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.
J Clin Oncol. 2009 Aug 1;27(22):3569-72. doi: 10.1200/JCO.2009.22.2117. Epub 2009 Jun 15. No Source available. Erratum in: J Clin Oncol. 2010 Dec 1;28(34):5126. Lippman, Scott M [added].
Source | Full text | Erratum | Similar articles



.

Vickers AJ, Savage CJ, Lilja H.
Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated?
J Clin Oncol. 2010 Mar 1;28(7):1112-6. doi: 10.1200/JCO.2009.23.5572. Epub 2010 Feb 1.
Source | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE

▲

.

Basal S, Wambi C, Acikel C, Gupta M, Badani K.
Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function.
BJU Int. 2013 Apr;111(4):658-65. doi: 10.1111/j.1464-410X.2012.11487.x. Epub 2012 Nov 27.
Source | Full text | Similar articles



.

Okajima K, Ishikawa K, Matsuura T, Tatebe H, Fujiwara K, Hiroi K, Hasegawa H, Nishimura Y.
Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy.
Int J Clin Oncol. 2012 Nov 20. [Epub ahead of print]
Source | Full text | Similar articles



INTEGRATIVE MEDICINE

▲

.

Gutt R, Tonlaar N, Kunnavakkam R, Karrison T, Weichselbaum RR, Liauw SL.
Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
J Clin Oncol. 2010 Jun 1;28(16):2653-9. doi: 10.1200/JCO.2009.27.3003. Epub 2010 Apr 26.
Source | Full text | Similar articles



PROGNOSIS

▲

.

Albertsen PC, Moore DF, Shih W, Lin Y, Li H, Lu-Yao GL.
Impact of comorbidity on survival among men with localized prostate cancer.
J Clin Oncol. 2011 Apr 1;29(10):1335-41. doi: 10.1200/JCO.2010.31.2330. Epub 2011 Feb 28.
Source | Full text | Similar articles



.

Crawford ED, Grubb R 3rd, Black A, Andriole GL Jr, Chen MH, Izmirlian G, Berg CD, D'Amico AV.
Comorbidity and mortality results from a randomized prostate cancer screening trial.
J Clin Oncol. 2011 Feb 1;29(4):355-61. doi: 10.1200/JCO.2010.30.5979. Epub 2010 Nov 1.
Source | Full text | Italian Full text | Similar articles



.

Gann PH, Fought A, Deaton R, Catalona WJ, Vonesh E.
Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach.
J Clin Oncol. 2010 Apr 1;28(10):1714-20. doi: 10.1200/JCO.2008.20.3422. Epub 2010 Feb 22.
Source | Full text | Similar articles



.

Heidegger I, Ladurner M, Skradski V, Klocker H, Schäfer G, Horninger W, Bektic J.
Adverse pathological findings in needle biopsy gleason score 6 prostate cancers with low and intermediate preoperative PSA levels following radical prostatectomy.
Anticancer Res. 2012 Dec;32(12):5481-5.
Source | Full text | Similar articles



.

Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM.
Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study.
J Clin Oncol. 2011 Feb 20;29(6):726-32. doi: 10.1200/JCO.2010.31.5226. Epub 2011 Jan 4.
Source | Full text | Similar articles



.

Røder MA, Thomsen FB, Christensen IJ, Toft BG, Brasso K, Vainer B, Iversen P.
Risk factors associated with positive surgical margins following radical prostatectomy for clinically localized prostate cancer: can nerve-sparing surgery increase the risk?
Scand J Urol. 2014 Feb;48(1):15-20. doi: 10.3109/00365599.2012.749425. Epub 2012 Nov 27.
Source | Full text | Similar articles



.

Ross AE, Loeb S, Landis P, Partin AW, Epstein JI, Kettermann A, Feng Z, Carter HB, Walsh PC.
Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program.
J Clin Oncol. 2010 Jun 10;28(17):2810-6. doi: 10.1200/JCO.2009.25.7311. Epub 2010 May 3.
Source | Full text | Similar articles



.

Steigler A, Denham JW, Lamb DS, Spry NA, Joseph D, Matthews J, Atkinson C, Turner S, North J, Christie D, Tai KH, Wynne C.
Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial.
Prostate Cancer. 2012;2012:814724. doi: 10.1155/2012/814724. Epub 2012 Dec 24.
Source | Full text | Similar articles



.

Uchio EM, Aslan M, Wells CK, Calderone J, Concato J.
Impact of biochemical recurrence in prostate cancer among US veterans.
Arch Intern Med. 2010 Aug 9;170(15):1390-5. doi: 10.1001/archinternmed.2010.262.
Source | Full text | Similar articles



TREATMENT

▲

.

Bechis SK, Carroll PR, Cooperberg MR.
Impact of age at diagnosis on prostate cancer treatment and survival.
J Clin Oncol. 2011 Jan 10;29(2):235-41. doi: 10.1200/JCO.2010.30.2075. Epub 2010 Dec 6.
Source | Full text | Similar articles



.

Cooperberg MR, Broering JM, Carroll PR.
Time trends and local variation in primary treatment of localized prostate cancer.
J Clin Oncol. 2010 Mar 1;28(7):1117-23. doi: 10.1200/JCO.2009.26.0133. Epub 2010 Feb 1.
Source | Full text | Similar articles



.

Kato K, Inoue T, Mizowaki T, Kamoto T, Kamba T, Shimizu Y, Norihisa Y, Yamada T, Hiraoka M, Yoshimura K, Ogawa O.
[Salvage hormonal therapy against recurrence after curative external beam radiotherapy for locally advanced prostate cancer at Kyoto University Hospital].
Hinyokika Kiyo. 2012 Nov;58(11):599-603. Japanese.
Source | Full text | Similar articles



.

Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A.
Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.
J Clin Oncol. 2010 Jan 1;28(1):126-31. doi: 10.1200/JCO.2009.24.2180. Epub 2009 Nov 16.
Source | Full text | Similar articles



.

Naiki T, Kawai N, Okamura T, Nagata D, Kojima Y, Akita H, Yasui T, Tozawa K, Kohri K.
Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomy.
BMC Urol. 2012 Dec 18;12:36. doi: 10.1186/1471-2490-12-36.
Source | Full text | Similar articles



.

Nguyen DP, Giannarini G, Seiler R, Schiller R, Thoeny HC, Thalmann GN, Studer UE.
Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site.
BJU Int. 2013 Aug;112(4):E243-9. doi: 10.1111/j.1464-410X.2012.11506.x. Epub 2012 Nov 27.
Source | Full text | Similar articles



.

Schröder F, Bangma C, Angulo JC, Alcaraz A, Colombel M, McNicholas T, Tammela TL, Nandy I, Castro R.
Dutasteride Treatment Over 2 Years Delays Prostate-specific Antigen Progression in Patients with Biochemical Failure After Radical Therapy for Prostate Cancer: Results from the Randomised, Placebo-controlled Avodart After Radical Therapy for Prostate Cancer Study (ARTS).
Eur Urol. 2013 May;63(5):779-87. doi: 10.1016/j.eururo.2012.11.006. Epub 2012 Nov 12.
Source | Full text | Similar articles



.

Smith DC, Smith MR, Sweeney C, Elfiky AA, Logothetis C, Corn PG, Vogelzang NJ, Small EJ, Harzstark AL, Gordon MS, Vaishampayan UN, Haas NB, Spira AI, Lara PN Jr, Lin CC, Srinivas S, Sella A, Schöffski P, Scheffold C, Weitzman AL, Hussain M.
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.
J Clin Oncol. 2013 Feb 1;31(4):412-9. doi: 10.1200/JCO.2012.45.0494. Epub 2012 Nov 19.
Source | Full text | Similar articles



bottom

▲